Virtus ETF Advisers’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-4,051
Closed -$68.7K 448
2024
Q4
$68.7K Buy
4,051
+1,132
+39% +$21.3K 0.03% 388
2024
Q3
$67.8K Buy
2,919
+54
+2% +$1.16K 0.03% 430
2024
Q2
$69.8K Sell
2,865
-222
-7% -$6.73K 0.03% 431
2024
Q1
$104K Sell
3,087
-215
-7% -$7.62K 0.06% 356
2023
Q4
$104K Sell
3,302
-280
-8% -$6.66K 0.07% 345
2023
Q3
$91.5K Sell
3,582
-354
-9% -$10.9K 0.06% 345
2023
Q2
$113K Sell
3,936
-1,431
-27% -$39K 0.07% 338
2023
Q1
$129K Sell
5,367
-2,064
-28% -$37K 0.07% 324
2022
Q4
$126K Sell
7,431
-661
-8% -$11.5K 0.07% 402
2022
Q3
$120K Buy
8,092
+53
+0.7% +$889 0.05% 398
2022
Q2
$127K Buy
8,039
+3,507
+77% +$68.8K 0.05% 363
2022
Q1
$122K Sell
4,532
-271
-6% -$6.92K 0.05% 264
2021
Q4
$178K Sell
4,803
-1,110
-19% -$45.2K 0.07% 253
2021
Q3
$283K Sell
5,913
-316
-5% -$14.2K 0.12% 206
2021
Q2
$211K Buy
6,229
+3,444
+124% +$117K 0.09% 307
2021
Q1
$115K Buy
2,785
+42
+2% +$2.5K 0.05% 349
2020
Q4
$119K Buy
+2,743
New +$186K 0.05% 350

Other funds holding ARCT